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Abstract
Conclusions: No positive effects of early preventive rehabilitation could be identiﬁed. The results do not contradict the
proposition that rehabilitation based on self-care can be effective but it is important to establish evidence-based training
programs and identify proper instruments for selection of patients and evaluation of intervention. Objectives: Patients with head
and neck cancer suffer from functional impairments due to intense treatment. In this study, we investigated the effectiveness of
an experimental early preventive rehabilitation using hard, objective end points in a nonselective, longitudinal, prospective
cohort study. Methods: In all, 190 patients were included in the program and received instructions for training before the start of
treatment with the aim of reducing swallowing problems and reducing mouth opening and stiffness in the neck. A control
group of 184 patients was recruited. Results: There was no difference in weight loss and 2-year survival between the two groups.
No positive effects concerning functional impairments were found in patient-reported outcome measures.
Keywords: Quality of life, functional impairment, loss of function, dysphagia, head neck, trismus, neck stiffness, sick leave,
speech problem
Introduction
More attention is being paid to functional impairment
and health-related quality of life (HRQOL) in patients
with tumor diseases [1]. This has arisen partly from
the fact that more patients survive and have a longer
expected survival after treatment. The clinical prob-
lem of impairment of physical functions in head and
neck cancer patients generally appears to be increas-
ing in patients receiving combined modality treat-
ment, probably due to progress in oncologic
treatment leading to better survival [2]. Some studies
have indicated increased loss of function and more
acute side effects if chemotherapy is added to the
treatment [3]. One feasible approach that requires
evaluation for improvement of HRQOL and reduc-
tion of the consequences of functional impairment is
rehabilitation.
Swallowing problems are considered to be the most
prominent symptom after treatment, and lead to
weight loss and probably also reduced HRQOL
[4–6]. Another important loss of function is stiffness
and pain in the neck and shoulders. These can be
related to both radiotherapy and surgery, especially
neck dissection, even if the accessory nerve is
preserved [7,8].
Traditionally, rehabilitation is initiated when loss
of function is already established. An alternative
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starting as soon as possible after diagnosis to prevent
development of functional impairments or to reduce
the extent of these problems [9]. To make this pos-
sible, a well-established clinical pathway including the
enrolment of patients into a preventive rehabilitation
program is crucial, without any delay in the start of
treatment [10].
The term cancer rehabilitation has been used in the
literature in a wide variety of ways. The lack of a
deﬁned role for rehabilitation in head and neck cancer
patients encouraged us to develop a self-training
program to reduce functional impairment. An exper-
imental clinical development program for early pre-
ventive rehabilitation was implemented in 2004 at one
of our two radiotherapy sites, as an integrated part of
the treatment.
We performed a prospective study on the integra-
tion and effectiveness of the early preventive rehabil-
itation program based on self-care. Our hypothesis
was that early preventive rehabilitation of head
and neck cancer patients can reduce functional
impairment and improve HRQOL, and thereby also
affect the survival.
Material and methods
This study was based on a clinical development pro-
gram ﬁnanced by the Swedish Cancer Society and
structured as a prospective nonrandomized study
comparing two parallel groups, one group undergoing
experimental early preventive rehabilitation and the
other group not being offered a systematic rehabili-
tation program. Patients were consecutively included
into both groups over 3.5 years and the ﬁrst year of
inclusion, 2004, functioned as a pilot study. Thereby
no selection of patients was made.
In Stockholm, all patients with head and neck
cancer are treated at one center, which is located at
Karolinska University Hospital. Patients are diag-
nosed at the Department of Otolaryngology and
Head and Neck Surgery, where the surgical treatment
is also performed. The Department of Oncology has
two units for radiotherapy (RT units) at two different
locations in Stockholm, the southern RT unit and the
northern RT unit.
Patients diagnosed with head and neck cancer in
Stockholm from January 1, 2004 to July 31, 2007 who
were to receive external beam radiotherapy with cura-
tive intent were included in the study. Patients treated
at the southern RT unit were offered experimental
early preventive rehabilitation and formed the study
group, while patients treated at the northern RT unit
did not undergo any early rehabilitation and they
made up the control group. Patients included in
the study group met with a speech pathologist and
a physiotherapist who were also part of the research
team. Patients included were sent a letter about the
study directly after diagnosis, to make sure they
received information about the study before the start
of treatment.
Early rehabilitation and evaluation by the speech
pathologist
All patients in the study group were examined by the
speech/language pathologist (SLP) before radiother-
apy and 3 months after completion of therapy. The
patients were instructed, both verbally and with writ-
ten information, on how to perform mobility exercises
for the tongue and larynx (Mendelson’s maneuver) at
least once and preferably twice a day at home during
the course of radiotherapy, and for 3 months after
termination of treatment. The tongue mobility exer-
cises consisted of ﬁve repetitions of extending the
tongue as far as possible straight out, up, down,
and laterally and then moving the tongue over the
whole inside of the oral cavity and teeth. Mendelson’s
maneuver, holding the larynx at its most superior
position for 2–3 s during swallowing, was to be
repeated 10 times. At each visit, the patient’s swallow-
ing, oral motor function, speech, and voice were
examined using clinical screening procedures. At
the clinical screening of swallowing, the patient was
asked to complete one swallow of two bolus sizes
(5 and 15 ml) of four consistencies: thin liquid, thick
liquid, paste, and cookie.Movement of the ﬂoor of the
mouth, hyoid, and thyroid cartilage was evaluated by
manual palpation during the act of swallowing. The
following swallowing parameters were clinically eval-
uated: oral manipulation and transport of bolus, pres-
ence of aspiration, laryngeal elevation, need for
several swallows, delayed initiation of swallowing,
and nasal regurgitation. Aspirations were noted as
cough, need to clear the throat, wet voice, or sudden
breathing difﬁculties. Patients with a risk of aspiration
or those refusing to participate were not given all
consistencies at all evaluation points. Voice and artic-
ulation were perceptually assessed by the SLP and the
tongue motility was assessed with tongue exercises.
Physiotherapy intervention and evaluation
The patients had an appointment with the physio-
therapist (PT) before the start of radiotherapy and
follow-ups were performed at 2, 6, and 12 months
after termination of treatment. The patients received
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stretching of muscles of the head and neck to maintain
mobility in the radiotherapy-exposed areas. The exer-
cises for preventing stiffness of the neck consisted of
active rotation of the head in both directions, ﬂexion/
extension of the head in a neutral position, and lateral
ﬂexions of the head, 3  10 times in each direction.
They also involved stretching of the platysma and
muscles of the neck. The patients were told that
the program should be performed twice a day and
performed before, during, and after radiotherapy until
follow-up at 6 months, and later if required. In cases
of postoperative radiotherapy after neck dissection,
the patients were told to pay extra attention to the
exercises since the radiotherapy would probably
worsen any already restricted head and neck mobility.
The prevention of trismus consisted of exercises
with the ‘Acute Medic Jaw Trainer and Stretcher’
(JTS) (www.acutemedic.com, Sweden). The pro-
gram of active mouth opening was done as active
maximal mouth opening assisted with the JTS for
10  20 s, twice a day. At follow-ups, the directions
could sometimes be changed to a ‘hold and release’
technique, depending on the need and/or compliance
of the patient.
The head and neck range of movements and mouth
opening (inter-incisial distance between upper and
lower left front teeth) was measured before the start of
treatment and at all follow-ups. The range of mobility
(ﬂexion, extension, rotation, and lateral ﬂexion) in the
head-neck region was measured with a Myrin goni-
ometer [11] that measured grades of movement.
Effect of treatment and rehabilitation
The body weight of the patient was measured rou-
tinely at diagnosis and at the follow-ups and registered
in the electronic patient ﬁles of the hospital. All
patients were offered dietary counseling by a dietician
before or at the start of radiotherapy and they were
given advice about high-calorie diets; when needed,
they were offered nutritional supplements. Patients
with swallowing problems and weight loss of >5% of
their initial body weight and patients with expected
nutritional problems caused by advanced tumor
(stage IV) were generally given enteral nutrition by
the use of a nasogastric tube or percutanous endo-
scopic gastrostomy.
Since patients in the control group did not meet the
SLP or PT for evaluation of functional loss, all
patients in both cohorts who were planned for cura-
tive radiotherapy at our weekly tumor meeting
were sent a set of questionnaires before the start of
treatment and 6 months after termination of treat-
ment, i.e. last surgery or last day of radiotherapy or
brachytherapy. The questionnaires used were
EORTC-QLQ-C30, EORTC-H&N35 (the Euro-
pean Organization for Research and Treatment of
Cancer), HADS (Hospital Anxiety and Depression
Scale), and a project-speciﬁc questionnaire.
The EORTC-QLQ-C30, the H&N35, and the
HADS are validated questionnaires for the aims
and study population of the present study [12–15].
The project-speciﬁc questionnaire focused on self-
reported functional losses and also contained ques-
tions about rehabilitation and working ability. The
ﬁrst version was constructed by the research team in
2004 after a literature review, and was tested in a pilot
study on a group of patients several months after
termination of radiotherapy. Thereafter, the question-
naire was adjusted according to information gained
from the patients. The project-speciﬁc questionnaire
is a Likert-type item scale that captures functional
impairments (24 items), patients’ satisfaction with
rehabilitation (11 items), return-to-work and sick
leave (5 items), demographic and social (5 items),
and one open question. The EORTC questionnaires
were analyzed according to the EORTC guidelines
provided by the EORTC network (http://www.eortc.
be/). The following cut-off levels were chosen for
HADS based on previous studies [15,16]: normal
corresponds to 0–7 points, mild depression/
anxiety corresponds to 8–10 points, moderate depres-
sion/anxiety corresponds to 11–15 points, and severe
depression/anxiety corresponds to 16–21 points.
Key measure for integration of the clinical development
program
The key measure used to evaluate the integration of
the intervention was the length of time between the
date of diagnosis and the start of radiotherapy.
Key measures for improvement and study end points
Weight loss and 2-year survival were chosen as the
principal measures of effect. Secondary outcome
measures were sick leave, self-reported loss of func-
tion, HRQOL, and anxiety/depression.
Sample size
At the planning stage of the study, it was anticipated
that in this population the proportion of patients with
no swallowing difﬁculties after treatment with tradi-
tionalrehabilitationwouldbeabout50%.Tobeableto
detect an absolute 15% improvement with early pre-
ventive rehabilitation, with 80% power, and with 5%
signiﬁcance level, it was estimated that 350 patients in
554 A. Ahlberg et al.total should be recruited to the study. With this sample
size, the predicted precision (95% conﬁdence interval
width forthe difference inproportions between the two
groups) would be about ±10%.
The patient population at the center during the
study period and loss of patients are shown
in Figure 1. In total, 456 patients were included
in the study, 82 in the pilot study and 374 in the
prospective study. Of these 374 patients, 205
answered the project-speciﬁc questionnaire at
6 months after termination of treatment, 84 in the
study group and 121 in the control group. The basic
characteristics of the 205 patients were not signiﬁ-
cantly different from those of the 169 patients not
answering the project-speciﬁc questionnaire, accord-
ing to the parameters listed in Table I.
Patient characteristics for the total patient material
included in the prospective study and separately for
the study and control groups are listed in Table I. The
basic characteristics of the two groups did not show
Total planned curative RT
2004–2007*:
515
Total 
included in 
study: 
456
Control group:
184 
Study group:
190
Control
group replied
P-S:
121
Study group
replied P-S:
84
Control 
group replied 
EORTC: 
BL: 39 pts
6 months: 42
Control
group replied
HAD:
BL: 44
6 months:
110
Study group
replied
HAD:
BL: 27
6 months: 73
Study group
replied
EORTC:
BL: 37
6 months: 33
 Total new patients 
2004–2007:
705
Included in
prospective
study:
374
Pilot study: 
82
 Loss of patients – 
none from research 
team present to 
include patient: 
59
Loss of patients–
not curative
radiotherapy
treatment:
190
Not answering 
P-S:
63
Not answering
P-S:
106
Figure 1. Inclusion of patients and loss of patients. P-S, project-speciﬁc questionnaire; BL, baseline (time of diagnosis); EORTC, includes
both QLQ-30 and H&N35. 6 months, 6 months after termination of treatment. *Year 2004 includes only patients treated at the southern RT
unit and year 2007 runs only until June 30, since the study was terminated after this.
Early rehabilitation of head and neck cancer patients 555any signiﬁcant differences and the groups were well
matched. There was a signiﬁcant difference in the
number of patients who received chemotherapy
between the RT units (p = 0.004).
Diagnosis and treatment
Patients were diagnosed by clinical examination,
CT scan of the head and neck and the thorax,
ultrasound-guided ﬁne-needle aspiration of metasta-
ses in the neck, and an endoscopic examination under
general anesthesia.
Radiotherapy was given at the two different radio-
therapy sites in Stockholm and dose plans were con-
structed according to local guidelines. Chemotherapy
was given either as induction treatment or as con-
comitant treatment. Brachytherapy was mainly used
for patients with tumors in the base of the tongue and
for some cases with tumor in the mobile part of the
tongue or the ﬂoor of the mouth.
Surgery was performed according to local guide-
lines at the Department of Otolaryngology and Head
and Neck Surgery at Karolinska University Hospital
following the same guidelines for both groups.
Follow-up
All patients were followed up for at least 2 years
according to set guidelines, with visits every third
month for the ﬁrst 2 years and thereafter every
6 months.
Statistical methods
Survival time was calculated from the date of the
multiprofessional treatment meeting to the date of
death, or until the common date for the end of
survival follow-up, August 1, 2009. Survival was
estimated according to the Kaplan-Meier technique
and differences in survival times were tested using
l o gr a n kt e s t .C o n ﬁdence interval for the reported
survival differences refers to the ﬁxed 2-year time
point.
Continuous variables were analyzed using linear
regression models. In these models, intervention is
included in the model as a categorical variable taking
the value of 0 for the control group and 1 for the study
group. For some continuous outcome variables, base-
line values were available. In these cases, models
were estimated including the baseline values as well
as the intervention variable. Differences in categorical
variables were tested using Fisher’s exact test. Binary
outcomes were modeled using ordinary logistic
regression models. For ordinal variables, distribu-
tional comparisons were performed using the
Mann-Whitney U test and the ordinal outcomes
were modeled using the proportional odds model.
The exponentiated intervention coefﬁcient in these
models can be interpreted as the ratio (between the
study group and control group) of the odds of being in
a higher (worse) rather than lower (better) category.
All effects from the regression models are presented
together with 95% conﬁdence intervals.
Table I. Patient characteristics.
Characteristics Total (%)
Patients answering the
project-
speciﬁc questionnaire (%)
Study group Control group
Age (years),
mean [SD]
63.7 (12.9) 63.6 (13.1) 64.1 (12.0)
Sex
Male 253 (68) 56 (67) 82 (68)
Female 121 (32) 28 (33) 39 (32)
Stage
I 40 (11) 9 (11) 17 (14)
II 51 (14) 16 (19) 19 (16)
III 76 (20) 12 (14) 23 (19)
IV 156 (42) 38 (45) 45 (37)
Missing 51 (14) 9 (11) 17 (14)
Site
Oral cavity 79 (21) 22 (26) 25 (21)
Oropharynx 111 (30) 26 (31) 33 (27)
Epipharynx 10 (3) 2 (2) 5 (4)
Hypopharynx 22 (6) 6 (7) 4 (3)
Larynx 47 (13) 8 (10) 14 (12)
Salivary gland 28 (8) 8 (10) 11 (9)
Nose and sinus 14 (4) 0 (0) 6 (5)
Other 63 (17) 12 (14) 23 (19)
Radiotherapy
Dose, mean [SD] 64 (6.8) 65 (5.7) 63 (7.3)
Preoperative RT 116 (31) 26 (31) 36 (30)
Postoperative RT 131 (35) 33 (39) 52 (43)
Only RT 122 (33) 25 (30) 32 (27)
Surgery
Any surgery 254 (68) 59 (70) 89 (74)
No surgery 120 (32) 25 (30) 32 (26)
Major surgery 6 (7) 12 (10)
Chemotherapy 86 (23) 10 (12) 35 (29)
Number of patients 374 84 121
Calculations of percentage and SD included patients with zero-
values. SD, standard deviation; RT, radiotherapy; ND, neck
dissection. Major surgery includes laryngectomy and free-
ﬂap reconstructions.
556 A. Ahlberg et al.Ethical considerations
The Research Ethics Board of Stockholm approved
the study by judging that no ethical approval was
required as it was identiﬁed as a clinical development
program (entry no.: 2005/767-31/1-4). The study was
performed according to the Declaration of Helsinki.
Results
Time between diagnosis and start of treatment
All patients undergoing radiotherapy at the site for
intervention (the southern RT unit) could be
included in the clinical development program. There
was no difference in time from diagnosis to start of
treatment between the study group (25.9 days,
SD = 30.5) and the control group (25.9 days,
SD = 30.4) (p = 0.99).
Weight loss and survival
There was no signiﬁcant difference in weight loss
(deﬁned as the change in weight from diagnosis to
6 months after treatment) between the study group
(–5.9 kg) and the control group (–6.2 kg), see Table
II. The difference in the incidence of patients with
weight loss of > 10%, although higher in the control
group, was not signiﬁcant.
Overall 2-year survival for all patients in the study
(n = 374) was 76% (95% CI: 71–80). There was no
signiﬁcant difference in 2-year survival between the
study group (n = 190) and the control group (n = 184)
(log rank, p = 0.49).
Working ability
As shown in Table II, a signiﬁcantly higher number
of patients in the control group who had been work-
ing before diagnosis had returned to work by
6 months after treatment, i.e. more patients in the
study group were still on sick leave and had not
returned to work.
Swallowing
Table III illustrates that patients in the control group
reported signiﬁcantly less swallowing difﬁculties than
those in the study group, with a proportional odds
ratio (OR) of 2.3 (95% CI: 1.3–4.0). In the control
group, 58% answered that they could swallow all
consistencies of food compared with 35% in the study
group (p < 0.001; data not shown in tables). There
were a signiﬁcantly higher number of patients using
high kilocalorie/protein supplement in the study
group (60%) than in the control group (32%)
(p < 0.001). The total incidence of reported swallow-
ing problems was 61% (114/185).
No difference in the incidence of dryness of the
mouth was found. The total incidence of patients
reporting any level of dryness of the mouth was
Table II. Comparison of outcome between study group and control group concerning weight loss and working ability.
Characteristics
Intervention study (%)
p value Difference (95% conﬁdence interval) n* Study group Control group
Weight loss* 197
Stable or increase 17 (21) 15 (13)
Decrease <;5% 18 (22) 27 (24)
Decrease 5–10% 27 (33) 30 (26)
Decrease >10% 21 (25) 42 (37) 0.23 –
Mean weight loss† in kg [SD] –5.8 (7.8) –6.2 (5.8) 0.68 0.4 (–1.5 to 2.3)
On sick leave at baseline 22
Situation unchanged at 6 months 7 (64) 7 (64)
Situation better at 6 months 4 (36) 4 (36) 1.0 –
Not on sick leave at baseline 133
Situation unchanged at 6 months 29 (55) 64 (80)
Situation worse at 6 months 24 (45) 16 (20) 0.003 25.2 (9.3 to 41.3)
Total number of patients 205 84 121
Calculations of percentage and SD included patients with zero-values.
*Number of patients included in the analysis.
†The difference in weight loss after controlling for baseline weight was not signiﬁcant (p = 0.42) and was estimated to be 0.7 (–1.0 to 2.4).
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that they had ‘very great’ problems with dryness of the
mouth was 41% (82/201).
Speech problems
There was a signiﬁcant difference in the extent of
speech problems, with an OR of 2.5 (95% CI:
1.4–4.4). In the study group, there was an increased
risk of being at a worse level (Table III).
Trismus and stiffness of the neck
In the total material, the incidence of chewing pro-
blems was 61% (113/186); 57% (106/186) reported a
reduced ability to open the mouth and 70% (133/189)
Table III. Comparison of outcome between study group and control group concerning self-reported loss of function 6 months after treatment.
Characteristics
Intervention study (%)
p value n Study group Control group
Do you have PEG? 167
1. Yes 12 (18) 15 (15)
2. No 46 (69) 71 (71)
3. No, but I used to have 9 (13) 14 (14) 0.88
Do you feel you have recovered after your treatment? 196
1. Yes, completely 4 (5) 18 (16)
2. Yes, partly 35 (42) 51 (45)
3. No 41 (49) 36 (32)
4. Don’t know 3 (4) 8 (7) 0.016
Swallowing difﬁculties* 185
1. Not at all 20 (26) 51 (47)
2. A little 27 (36) 35 (32)
3. Quite a bit 23 (30) 16 (15)
4. Very much 6 (8) 7 (6) 0.003
Chewing difﬁculties* 186
1. Not at all 28 (38) 45 (40)
2. A little 21 (29) 31 (27)
3. Quite a bit 18 (25) 22 (20)
4. Very much 6 (8) 15 (13) 0.94
Reduced ability to open mouth* 187
1. Not at all 25 (34) 56 (50)
2. A little 20 (27) 28 (25)
3. Quite a bit 21 (28) 23 (20)
4. Very much 8 (11) 6 (5) 0.018
Speech problems* 184
1. Not at all 20 (28) 54 (48)
2. A little 26 (36) 39 (35)
3. Quite a bit 16 (22) 11 (10)
4. Very much 10 (14) 8 (7) 0.001
Stiffness in the neck/shoulders* 189
1. Not at all 23 (31) 33 (29)
2. A little 27 (36) 47 (41)
3. Quite a bit 20 (27) 22 (19)
4. Very much 5 (7) 12 (11) 0.98
*Data treated as ordinal.
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after termination of treatment. There was an OR of
1.9 (95% CI: 1.1–3.3) with an increased risk of
reduced ability to open the mouth in the study group
relative to the control group. However, there was no
difference between the groups concerning chewing of
food. There was also no difference in stiffness of the
neck and shoulders (Table III).
HRQOL and anxiety/depression
These parameters are described in Table IV.
Response frequency was lower in EORTC than in
the project-speciﬁc questionnaire. No parameters in
the EORTC or the HADS showed any signiﬁcant
difference between the two groups at 6 months after
termination of treatment. At 6 months after treat-
ment, the total incidence of depression at any level
(mild to severe) was 27% (50/183).
Discussion
Disability dominated by reduced functional capacity
is common in head and neck cancer patients after
treatment. We have implemented a clinical develop-
ment program based on self-care, aimed at rehabili-
tating patients treated for head and neck cancer
with radiotherapy combined or not combined
with surgery, chemotherapy, or brachytherapy. The
clinical development program concentrates on
maintaining swallowing function and mobility of
the jaw and neck. Our hypothesis was that an
improvement can be achieved by invoking early pre-
ventive rehabilitation that starts before treatment and
is conducted by a speech/language pathologist and a
physiotherapist [10]. The present study is a nonse-
lective, longitudinal, prospective cohort study evalu-
ating the effect of the experimental early preventive
rehabilitation.
Rehabilitation has been tested clinically and exper-
imentally and is an area of great interest but a gold
standard is still not available. There are different ways
to perform experimental early rehabilitation. One
common approach is to select a smaller group of
patients based on their speciﬁc needs and to provide
them with an intense program with frequent evalua-
tions [17]. An alternative model used in the current
study is to include all possible patients without selec-
tion before treatment and increase the patient activa-
tion and involvement by self-care. Another motive for
research on preventive rehabilitation based on self-
care is resource utilization aiming to provide a cost-
effective alternative that could be used in treatment
decisions.
For the majority of patients, delay in treatment
would be associated with a less favorable prognosis
and it is therefore most important that preventive
rehabilitation should not affect the start of treatment
[18]. An important ﬁnding is that no delay in the start
of treatment was found in patients undergoing early
rehabilitation, indicating that a rehabilitation program
like this could be effectively integrated into the exist-
ing clinical routines.
The instruments for evaluation and outcome vari-
ables in earlier studies have been variable. Here the
critical end points were weight loss and 2-year sur-
vival, which are strong objective values that can be
continuously followed through the patients medical
ﬁles. No difference between the study group and the
control group was found concerning weight loss or
2-year survival. It might be argued that the applied
primary outcome measure weight loss might be too
rigid and not fully relevant for determining the effec-
tiveness of early preventive rehabilitation. The local
nutritional guidelines might have inﬂuenced the pri-
mary outcome measure weight loss more than the
rehabilitation program focused on self-care regarding
swallowing. It is also less probable that survival would
be affected by this kind of rehabilitation program.
However, survival is a strong objective parameter
that is often discussed in association with quality of
life and reﬂects not only cancer death but also non-
cancer mortality associated with treatment.
The analysis of the patient-reported outcome
measures also showed no positive effects of the
Table IV. Comparison between study group and control group
concerning global health (EORTC QLQ-30) and depression and
anxiety (HAD-S) measured 6 months after treatment.
Characteristics
Intervention study (%)
p value n
Study group
Mean (SD)
Control group
Mean (SD)
HAD-S
Depression 183
1. Normal (0–7) 54 (74) 79 (72)
2. Mild (8–10) 11 (15) 16 (15)
3. Moderate (11–15) 5 (7) 14 (13)
4. Severe (16–21) 3 (4) 1 (1) 0.75
Anxiety 189
1. Normal (0–7) 53 (70) 81 (72)
2. Mild (8–10) 8 (11) 13 (12)
3. Moderate (11–15) 11 (15) 17 (15)
4. Severe (16–21) 4 (5) 2 (2) 0.66
EORTC QLQ-30
Global health status
75 56.6 (23.4) 61.4 (23.0) 0.29
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early preventive rehabilitation based on self-care was
not superior to conventional follow-up in consecutive
head and neck cancer patients. Furthermore, it was
found that patients who received early rehabilitation
scored signiﬁcantly lower on the project-speciﬁc self-
report questionnaire concerning swallowing and jaw
mobility. It should be noted that signiﬁcantly more
patients in the control group received chemotherapy
and might therefore be expected to suffer from more
morbidity than the study group.
The results of the current study cannot therefore
conﬁrm the observations of Carroll et al. [4] in a
retrospective case control study of nine patients who
underwent pretreatment swallowing exercises. This
discrepancy may be accounted for by the fact that they
used a limited sample size and selected patients for
training of the swallowing function. Nor could the
current study conﬁrm the positive outcome of pre-
treatment swallowing education and exercise found
by Kulbersh et al. [9] in a study involving 37 patients
using the MD Anderson Dysphagia Inventory
(MDADI) questionnaire. A possible interpretation
of the ﬁndings in the current study is that after
detailed information and self-care, patients in the
study group were more aware of swallowing problems
and the importance of nutritional intake before ther-
apy, and therefore had higher expectations concern-
ing their functional status than the control group.
It is believed that a considerable number of patients
with head and neck cancer have a low HRQOL
already before the onset of symptoms, and could
therefore be a complicated and complex group to
rehabilitate [19]. The two groups of patients in the
present study were similar in many aspects, although
we have not analyzed socioeconomic factors thor-
oughly. The employment of other social variables
might have been important parameters to analyze,
since there were more patients who had worked before
diagnosis still on sick leave in the study group than in
the control group 6 months after treatment.
The clinical development program was running for
3.5 years and was thereafter implemented as clinical
routine before the data from the current study had
been thoroughly analyzed. As a worse outcome was
revealed for the rehabilitation group in some domains
in the project-speciﬁc questionnaire one may question
a continuation of preventive rehabilitation in a clinical
setting. However, there are no obvious indications
that the experimental early rehabilitation program
itself aggravated the functional impairments. It is
well known from several earlier rehabilitation studies
in different medical ﬁelds that rehabilitation out-
comes can be hard to assess. Nevertheless rehabilita-
tion based on self-care in the present form does not
seem to be a promising strategy to reduce disability in
the majority of patients that are treated for head and
neck cancer. The idea of totally abandoning the
concept of preventive rehabilitation in this patient
group is not justiﬁed by the results in this study.
Instead there is now a need to take a further step
and ﬁnd new approaches for preventive rehabilitation
with the goal of maintaining swallowing function,
speech, and motility of the jaw and neck.
As far as we are aware, there have been no previous
studies evaluating self-care for early preventive reha-
bilitation in a large sample of unselected head and
neck cancer patients. However, as stated in previous
reports, this is much needed. In the light of previous
studies of swallow exercise programs showing encour-
aging outcomes there are two major considerations
regarding the negative results of the early rehabilita-
tion program. First, the determinants of rehabilitation
may have been insufﬁcient to detect minor positive
effects of the program. Second, the model for early
rehabilitation based on self-care before, during, and
after treatment with just a few follow-ups may have
produced an ambivalent attitude in patients. It could
be speculated that another design for early preventive
rehabilitation might have had a favorable outcome.
The lack of positive results justiﬁes reconsideration of
a randomized controlled trial of early rehabilitation of
head and neck cancer patients. We recommend that
such a study should use more regular surveillance and
physical evaluation of patients in both the study group
and the control group.
Conclusion
An early rehabilitation program including head and
neck cancer patients in general was introduced with-
out extending the period between diagnosis and treat-
ment. However, this study could not show any
positive effect of early preventive rehabilitation based
on self-care. It is important to identify proper instru-
ments for evaluation of early rehabilitation.
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